World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
61
Citations
15882
World Ranking
3210
National Ranking
143

Overview

Laurence Weiss is affiliated with Université Paris Cité in France and has contributed extensively to medical research with a particular focus on infectious diseases and immunology. Their scholarly work spans various subfields including infectious diseases, epidemiology, virology, hepatology, and emergency medicine.

The researcher's primary fields of study include Medicine and Immunology and Microbiology, with a significant body of work related to HIV research and treatment. Weiss's research covers several key topics such as HIV/AIDS research and interventions, hepatitis C virus research, HIV-related health complications and treatments, HIV/AIDS drug development and treatment, hepatitis B virus studies, and the intersection of HIV with drug use and sexual risk.

Laurence Weiss has published in multiple scientific journals, with frequent contributions to the following venues:

  • Journal of Antimicrobial Chemotherapy
  • Clinical Infectious Diseases
  • Clinical Gastroenterology and Hepatology
  • SSRN Electronic Journal
  • Revue du Rhumatisme

Some recent papers authored or co-authored by Weiss include:

  • "Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients," 2022, Clinical Microbiology and Infection
  • "HIV infection and COVID-19: risk factors for severe disease," 2020, AIDS
  • "Weight Loss and Weight Regain in Usual Clinical Practice: Results From the TARGET-NASH Observational Cohort," 2021, Clinical Gastroenterology and Hepatology
  • "CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies," 2020, Clinical Infectious Diseases
  • "Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers," 2022, Nature Communications

Weiss collaborates frequently with other researchers such as Laurence Meyer, Jean-Michel Molina, Cécile Goujard, Dominique Costagliola, and Didier Laureillard, each of whom has co-authored multiple publications with Weiss.

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Anti–Factor H Autoantibodies Associated with Atypical Hemolytic Uremic Syndrome

    Marie-Agnès Dragon-Durey;Chantal Loirat;Sylvie Cloarec;Marie-Alice Macher

  • Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients.

    Laurence Weiss;Vladimira Donkova-Petrini;Laure Caccavelli;Michèle Balbo

  • Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy.

    Sophie Grabar;Vincent Le Moing;Cécile Goujard;Catherine Leport

  • Heterozygous and Homozygous Factor H Deficiencies Associated with Hemolytic Uremic Syndrome or Membranoproliferative Glomerulonephritis: Report and Genetic Analysis of 16 Cases

    Marie-Agnès Dragon-Durey;Véronique Frémeaux-Bacchi;Chantal Loirat;Jacques Blouin

  • Enhanced T cell recovery in HIV-1–infected adults through IL-7 treatment

    Yves Levy;Christine Lacabaratz;Laurence Weiss;Jean-Paul Viard

  • CD14lowCD16high: A cytokine‐producing monocyte subset which expands during human immunodeficiency virus infection

    Nathalie Thieblemont;Laurence Weiss;Hoss M. Sadeghi;Claudia Estcourt

  • DISCREPANT RESPONSES TO TRIPLE COMBINATION ANTIRETROVIRAL THERAPY IN ADVANCED HIV DISEASE

    Piketty C;Castiel P;Belec L;Batisse D

  • The split personality of regulatory T cells in HIV infection

    Mathieu F. Chevalier;Mathieu F. Chevalier;Laurence Weiss;Laurence Weiss

  • Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV.

    Sophie Grabar;Hana Selinger-Leneman;Sophie Abgrall;Gilles Pialoux

  • Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen.

    Christophe Piketty;Laurence Weiss;François Thomas;Ali Si Mohamed

  • Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection : a randomised controlled trial

    Y Levy;C Capitant;S Houhou;I Carriere

  • HIV infection in older patients in the HAART era

    Sophie Grabar;Laurence Weiss;Dominique Costagliola

  • Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial

    José R Arribas;Pierre-Marie Girard;Roland Landman;Judit Pich

  • Human complement factor H deficiency associated with hemolytic uremic syndrome.

    Nathalie Rougier;Michel D. Kazatchkine;Jean-Philippe Rougier;Veronique Fremeauxbacchi

  • Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapy.

    Christophe Piketty;Esther Race;Philippe Castiel;Laurent Belec

  • Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy.

    Jeanne Serpaggi;Marie-Laure Chaix;Dominique Batisse;Caroline Dupont

  • Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients

    Unknown

  • Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial.

    Yves Levy;Christine Durier;Roman Krzysiek;Claire Rabian

  • CD14+CD16++ cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell-like characteristics

    Petronela Ancuta;Laurence Weiss;Nicole Haeffner-Cavaillon

  • Drug resistance profiles for the HIV integrase gene in patients failing raltegravir salvage therapy.

    C Charpentier;M Karmochkine;D Laureillard;P Tisserand

Frequent Co-Authors

Michel D. Kazatchkine
Michel D. Kazatchkine Université Paris Cité
Cécile Goujard
Cécile Goujard University of Paris-Saclay
Laurent Bélec
Laurent Bélec Université Paris Cité
Christine Rouzioux
Christine Rouzioux Necker-Enfants Malades Hospital
Pierre-Marie Girard
Pierre-Marie Girard Institut Pasteur
Nicole Haeffner-Cavaillon
Nicole Haeffner-Cavaillon Inserm : Institut national de la santé et de la recherche médicale
Jean-Paul Viard
Jean-Paul Viard Assistance Publique – Hôpitaux de Paris
Christine Katlama
Christine Katlama Sorbonne University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Immunology opens doors to various healthcare roles requiring specialized education. Many students consider pathways like becoming a Licensed Practical Nurse (LPN) or a Nurse Practitioner, both of which play critical roles in patient care and immunological health.

If you're starting out, finding easy LPN programs to get into can provide a swift entry into nursing with practical skills directly applicable to immunology settings. For advanced practice roles, look into nurse practitioner programs with easy admission, which can help fast-track your career growth.

Mental health is closely linked to immunology research and patient wellness. Programs like the top PMHNP programs offer well-structured clinical placements that enhance learning and practical experience in psychiatric nursing, often intersecting with immune system health.

Cost is a significant factor for many students. Seeking affordable options by exploring cheapest online PMHNP programs can provide a quality education without financial strain, making advanced nursing degrees more accessible.

Combining knowledge in immunology with these diverse nursing pathways broadens your career prospects and impact in healthcare.

Best Scientists Citing Laurence Weiss

Trending Scientists